2.50
Hdl Handle:
http://hdl.handle.net/10033/621090
Title:
Fumitremorgins and Relatives - from Tremorgenic Compounds to Valuable Anti-Cancer Drugs.
Authors:
Abraham, Wolf-Rainer ( 0000-0002-2850-2649 )
Abstract:
Fumitremorgins are mycotoxins but can also inhibit cancer cells and reverse their drug resistance.
Affiliation:
Hemholtz Centre for infection research, Inhoffenstr.7, 38124 Braunschweig, Germany.
Citation:
Fumitremorgins and Relatives - from Tremorgenic Compounds to Valuable Anti-Cancer Drugs. 2017 Curr. Med. Chem.
Journal:
Current medicinal chemistry
Issue Date:
24-Jul-2017
URI:
http://hdl.handle.net/10033/621090
DOI:
10.2174/0929867324666170724103410
PubMed ID:
28738771
Type:
Article
Language:
en
ISSN:
1875-533X
Appears in Collections:
publications of the research group chemical microbiology (CMIK)

Full metadata record

DC FieldValue Language
dc.contributor.authorAbraham, Wolf-Raineren
dc.date.accessioned2017-09-04T13:45:18Z-
dc.date.available2017-09-04T13:45:18Z-
dc.date.issued2017-07-24-
dc.identifier.citationFumitremorgins and Relatives - from Tremorgenic Compounds to Valuable Anti-Cancer Drugs. 2017 Curr. Med. Chem.en
dc.identifier.issn1875-533X-
dc.identifier.pmid28738771-
dc.identifier.doi10.2174/0929867324666170724103410-
dc.identifier.urihttp://hdl.handle.net/10033/621090-
dc.description.abstractFumitremorgins are mycotoxins but can also inhibit cancer cells and reverse their drug resistance.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleFumitremorgins and Relatives - from Tremorgenic Compounds to Valuable Anti-Cancer Drugs.en
dc.typeArticleen
dc.contributor.departmentHemholtz Centre for infection research, Inhoffenstr.7, 38124 Braunschweig, Germany.en
dc.identifier.journalCurrent medicinal chemistryen
This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.